y-Glutamylcysteine synthetase is one of the enzymes of glutathione (GSH) synthesis. A deficiency of this enzyme has been found only once previously in humans: it was associated with spinocerebellar degeneration and hemolytic anemia. We report the case of a woman, daughter of fifth cousins, who was y-glutamylcysteine-synthetasedeficient. Modest decreases in the amount of GSH in cultured lymphoblasts and fibroblasts could be documented. The amount of residual enzyme was insufficient to permit detailed studies of the characteristics of the mutant EDUCED GLUTATHIONE (GSH) plays a vital role R in the metabolism of all cells. A tripeptide composed of glutamic acid, cysteine, and glycine, GSH is synthesized in two sequential reactions. The first is catalyzed by yglutamylcysteine synthetase and the second by glutathione synthetase.
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Deficiency of red blood cell (RBC) GSH is a relatively uncommon cause of hereditary nonspherocytic hemolytic anemia. Less than a dozen cases have been documented,' and we found only one patient with GSH deficiency in a recent survey* of over 600 patients with hemolytic anemia. Of the relatively small number of patients with RBC GSH deficiency, only two members in one family manifested a defect of the first step of GSH synthesis; all others were deficient in GSH synthetase. In the single family with y-glutamylcysteine synthetase deficiency, spinocerebellar degeneration was present in addition to chronic hemolytic anemia,3 and the neurologic findings were considered to be a consequence of the hereditary enzyme defi~iency.~
We report the second family in which this enzymatic defect has been documented and show that neurologic symptoms are not necessary manifestations of this enzyme defect.
CASE REPORT
A 22-year-old woman enjoyed excellent general health. She is of Polish extraction and her mother and father were fifth cousins; the family had kept unusually good records and the patient's great, great, great, great grandfathers were known to have been brothers. Transient jaundice was reported at the age of 11, complicating an unspecified viral infection. At age 21, being followed with a normal pregnancy, she was found to be anemic, with the hematocrit of 28% and reticulocyte count of 13.6%. Her Coombs' test was normal, but no further investigation of the anemia was performed and she was transfused with 2 U of RBCs just before delivery. After delivery of a healthy male infant, she continued to be anemic with increased reticulocyte counts. Further investigations showed an elevated serum lactate dehydrogenase, decreased serum haptoglobin, elevated plasma iron and ferritin levels, and normal serum vitamin B,, and folate levels. A liver/spleen scan was normal. The patient was found to have a hematocrit of 38.5% with a reticulocyte count of 11.5%. A blood film showed marked macrocytosis. There were rare elliptocytes and occasional tear-drop cells. Osmotic fragility and a Ham test were normal. Ultrasound studies revealed no evidence of gallstones. A complete neurologic exam was normal. Specifically, there was no evidence of cerebellar dysfunction or any focal neurologic signs.
enzymes, but no major abnormality in its K, for cysteine and glutamic acid or in its heat stability were found. In contrast to the earlier report, the only manifestation of the enzyme deficiency was hemolytic anemia. This leads us to conclude that either the occurrence of neurologic symptoms in the other reported family was a chance association or that the clinical expression of this rare defect is pleomorphic. 0 1990 by The American Society of Hematology.
SPECIAL STUDIES
A panel of 23 RBC enzyme assays and four metabolic intermediates was performedsT6 as shown in Table 1 . Notably, RBC GSH concentration was only 0.7 pmol/g hemoglobin, approximately 10% of the mean normal. The activity of y-glutamylcysteine synthetase was markedly diminished to about 6% of the mean normal, while GSH synthetase activity was within normal limits. In addition, the GSH-S-transferase activity was markedly reduced. Although there were modest increases in the RBC creatine and hexokinase activities, sensitive indicators of RBC age, the increases were surprisingly modest for a patient with a reticulocyte count of 11%, and the activities of other age-related enzymes such as glucose-&phosphate dehydrogenase and pyruvate kinase were within the normal range.
RBCs of the patient were further fractionated into reticulocyte-rich and reticulocyte-poor fractions by PercollHypaque ~entrifugation.~ y-Glutamylcysteine-synthetase, GSH-S-transferase, and glutathione levels of reticulocyterich and reticulocyte-poor fractions were determined as shown in Table 2 . The y-glutamylcysteine-synthetase deficiency was least severe in the reticulocyte-rich fractions. Correspondingly, RBC GSH deficiency was most severe in the reticulocyte-poor fraction, indicating that most of the meager amount of GSH that was found in the whole blood was actually confined to the reticulocyte. Similarly, the glutathione-S-transferase activity of the cells was normal in the reticulocyte-rich fraction, but the activity of the enzyme was markedly decreased in the reticulocyte-poor fraction.
Measurements of the total glutathione content of cultured skin fibroblasts and transformed lymphoblasts from the 8EUTLER ET AL patients and normal controls was performed using the cycling method.' The GSH concentration of the patient's fibroblasts was 7.1 pmol/g protein; two normal control cultures gave values of 10.5 and 12.8 pmol/g protein. The patient's lymphoblast GSH was 12.2 pmol/g protein, compared with 27.3 and 21.7 pmol/g protein for two controls.
Because of the small amount of residual activity of RBC y-glutamylcysteine-synthetase, only approximations of K, values were possible. Normal cells were found to have a K, of 1.35 t 0.44 mmol/L for glutamic acid and of 0.105 * 0.02 There was no demonstrable abnormality in the thermal stability of the patient's enzyme. y-Glutamylcysteine-synthetase assays were performed on cultured lymphoblasts and cultured skin fibroblasts from the patient. Very high blank activities were obtained both from the patient's and normal control cells, suggesting hydrolysis of adenosine triphosphate (ATP) by pathways independent of the presence of cysteine. This could not be overcome by use of a blank without glutamate, high speed centrifugation, ouabain inhibition of adenosine triphosphatase (ATPase), or dialysis.
It was possible to examine the RBCs of the patient's son, mother, and maternal grandmother. The y-glutamylcysteine synthetase activities of the RBCs of these family members were each about 50% of normal, at 0.56, 0.54, and 0.63 U/g hemoglobin. GSH synthetase and RBC GSH levels were normal in all.
DISCUSSION
Establishing a cause-and-effect relationship between an enzyme deficiency and a clinical syndrome requires the study of several families. y-Glutamylcysteine-synthetase deficiency appears to be so rare in humans that this has not been possible; heretofore only a single family, first documented in 1972,3 has been reported. We now report a new patient unrelated to the original family. Hemolytic anemia was present in all of the patients, but only members of the first family reported manifested spinocerebellar degeneration. Thus, it is evident that neurologic changes are not a necessary part of y-glutamylcysteine-synthetase deficiency. One cannot discount the possibility that two different genetic forms of this enzyme deficiency exist: one causing a neurologic deficit while the other does not. There are ample precedents for such a circumstance. In the other form of GSH deficiency, that caused by GSH synthetase deficiency, two distinct clinical forms exist. In one group of patients only hemolytic anemia is present, while in the others oxoprolinuria and neuromuscular disorders are additional manifestations of the enzyme deficiency. Presumably, RBCs are affected in only one form of the disease, while the defect is generalized in the other Similarly, hereditary methemoglobinemia due to cytochrome b, reductase deficiency exists in a generalized form characterized by mental retardation",'* as well as methemoglobinemia, and a form in which methemoglobinemia is the only manife~tation.'~.'~ From a biochemical point of view, it is of interest that age-related RBC enzyme activities were normal in spite of a reticulocyte count that was consistently in excess of 10%. It is possible that the low GSH level of the RBCs impairs the stability of some RBC enzymes. As we have noted previously in a patient with GSH synthetase deficiency, this is certainly the case with GSH-S-transferase. In vitro, this enzyme is readily inactivated by electrophilic compounds in the absence of GSH. Such inactivation apparently also occurs in vivo. Thus, RBCs of patients who have deficiencies of GSH synthesizing enzymes appear consistently to have very low GSH-S-transferase activity.
RBC GSH assays are simple to perform. As RBCs of more patients with hemolytic anemia and/or neurologic disease are examined for the levels of this tripeptide, further cases of y-glutamylcysteine-synthetase deficiency will surely come to light, and may serve to clarify the spectrum of clinical disorders produced by this rare enzyme deficiency.
